IL7 and malignant biphasic mesothelioma: This result seems independent on the MPM subtypes (Table 2) given that IL7 expression was similar in epithelioid mesothelioma (EM), sarcomatoid mesothelioma (SM), biphasic mesothelioma (BM), and diffuse malignant mesothelioma (DM) (Fig. S8A) and that the prognostic value of IL7 expression was also confirmed in EM patients (Fig. S8B).